The Myeloid Receptor PILRβ Mediates the Balance of Inflammatory Responses through Regulation of IL-27 Production
Cristina M. Tato(Chan Zuckerberg Initiative (United States)), Terrill K. McClanahan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Manjiri Sathe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Man-Ru Liu(Nanchang University), Sarah E. Ewald(Carter Center), Yi Chen(Nanjing University of Chinese Medicine), Joseph H. Phillips(University of Maryland, Baltimore County), Daniel M. Gorman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Barbara Joyce-Shaikh(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul G. Heyworth(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 23
Related Papers
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells
|The Journal of Experimental Medicine|1997|360